Dentists in Alturas, CA Accepting Medicare
3 Dentists found. Showing 1 - 3
 Dr. Norman Dennis Ensminger, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 110 E 12th St, Alturas, CA 96101 Phone: 530-233-3543 Fax: 530-233-6752 |
Dr. Amin Azizi Zahirfar, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 222 Mcdowell Ave, Alturas, CA 96101 Phone: 530-233-4240 Fax: 530-233-4198 |
Dr. Edward S Fass, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 224 Mcdowell Street, Alturas, CA 96101 Phone: 530-233-2034 |
News Archive
Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination
Eli Lilly and Company announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.
Finnish researchers come together to study airborne transmission of coronavirus
Aalto University, the Finnish Meteorological Institute, VTT Technical Research Centre of Finland and the University of Helsinki have brought together a multidisciplinary group of researchers to model how the extremely small droplets that leave the respiratory tract when coughing, sneezing or talking are transported in air currents.
Moderate-intensity exercise reduces fat deposits in people with diabetes mellitus
Moderate-intensity exercise reduces fat stored around the heart, in the liver and in the abdomen of people with type 2 diabetes mellitus, even in the absence of any changes in diet, according to a new study published online in the journal Radiology.
GFT505 demonstrates dose-dependent efficacy on primary endpoint in phase 2 NASH trial
GENFIT, today announces topline results of the phase 2 GOLDEN-505 trial in NASH. Due to the unexpected rate of resolution of NASH in patients randomized to placebo who had early NASH (NAS of 3, placebo response rate>57%), along with the high number of sites for a limited sample size, the study as initially designed did not enable the trial to meet directly the primary endpoint.
Merck announces collaboration to create Calibr for early-stage translational research
Merck, known outside the United States and Canada as MSD, today announced a collaboration to create the California Institute for Biomedical Research (Calibr), an independent, not-for-profit organization (501c3) established to accelerate the translation of basic biomedical research into innovative, new medicines to treat disease.
› Verified 1 days ago
Counselors
Pharmacists
Clinical Social Workers
Psychologists
Dentists